We have previously identified the BRCA2 c.68-7T>A in a breast cancer kindred, and we then expanded the family to show multiple cases of breast cancer cases with the variant, categorized the variant as pathogenic, and subjected the variant carriers to health care according to the accepted standard [4]. This evidence concerns the gene BRCA2 and breast cancer.